BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ren Q. Soluble Epoxide Hydrolase Inhibitor: A Novel Potential Therapeutic or Prophylactic Drug for Psychiatric Disorders. Front Pharmacol 2019;10:420. [PMID: 31105566 DOI: 10.3389/fphar.2019.00420] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Zheng S, Guo J, Xin Q, Galfalvy H, Ye Y, Yan N, Qian R, Mann JJ, Li E, Xue X, Yin H. Association of adenosine triphosphate-related genes to major depression and suicidal behavior: Cognition as a potential mediator. Journal of Affective Disorders 2022. [DOI: 10.1016/j.jad.2022.11.042] [Reference Citation Analysis]
2 Han WW, Wang XR, He YF, Zhang HS, Cong X, Xiang RL, Wu LL, Yu GY, Liu LM, Zhang Y. Soluble epoxide hydrolase inhibitor, t-AUCB, improves salivary gland function by ameliorating endothelial injury. Life Sci 2022;308:120942. [PMID: 36096247 DOI: 10.1016/j.lfs.2022.120942] [Reference Citation Analysis]
3 Kytikova O, Denisenko Y, Novgorodtseva T, Bocharova N, Kovalenko I. Fatty acid epoxides in the regulation of the inflammation. BIOMED KHIM 2022;68:177-189. [DOI: 10.18097/pbmc20226803177] [Reference Citation Analysis]
4 Shan J, Hashimoto K. Soluble Epoxide Hydrolase as a Therapeutic Target for Neuropsychiatric Disorders. Int J Mol Sci 2022;23:4951. [PMID: 35563342 DOI: 10.3390/ijms23094951] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Mayo-Martínez L, Rupérez FJ, Martos-Moreno GÁ, Graell M, Barbas C, Argente J, García A. Unveiling Metabolic Phenotype Alterations in Anorexia Nervosa through Metabolomics. Nutrients 2021;13:4249. [PMID: 34959800 DOI: 10.3390/nu13124249] [Reference Citation Analysis]
6 Liu T, Li T, Chen X, Li Z, Feng M, Yao W, Wan L, Zhang C, Zhang Y. EETs/sEHi alleviates nociception by blocking the crosslink between endoplasmic reticulum stress and neuroinflammation in a central poststroke pain model. J Neuroinflammation 2021;18:211. [PMID: 34530836 DOI: 10.1186/s12974-021-02255-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Zhao WY, Yan JJ, Zhang M, Wang C, Feng L, Lv X, Huo XK, Sun CP, Chen LX, Ma XC. Natural soluble epoxide hydrolase inhibitors from Inula britanica and their potential interactions with soluble epoxide hydrolase: Insight from inhibition kinetics and molecular dynamics. Chem Biol Interact 2021;345:109571. [PMID: 34217688 DOI: 10.1016/j.cbi.2021.109571] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
8 Bzówka M, Mitusińska K, Hopko K, Góra A. Computational insights into the known inhibitors of human soluble epoxide hydrolase. Drug Discov Today 2021;26:1914-21. [PMID: 34082135 DOI: 10.1016/j.drudis.2021.05.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
9 Hasumi K, Suzuki E. Impact of SMTP Targeting Plasminogen and Soluble Epoxide Hydrolase on Thrombolysis, Inflammation, and Ischemic Stroke. Int J Mol Sci 2021;22:954. [PMID: 33477998 DOI: 10.3390/ijms22020954] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
10 Sun CP, Zhang XY, Morisseau C, Hwang SH, Zhang ZJ, Hammock BD, Ma XC. Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical Synthesis and Natural Products. J Med Chem 2021;64:184-215. [PMID: 33369424 DOI: 10.1021/acs.jmedchem.0c01507] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 13.0] [Reference Citation Analysis]
11 He X, Zhao W, Shao B, Zhang B, Liu T, Sun C, Huang H, Wu J, Liang J, Ma X. Natural soluble epoxide hydrolase inhibitors from Inula helenium and their interactions with soluble epoxide hydrolase. International Journal of Biological Macromolecules 2020;158:1362-8. [DOI: 10.1016/j.ijbiomac.2020.04.227] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
12 Warner J, Hardesty J, Zirnheld K, McClain C, Warner D, Kirpich I. Soluble Epoxide Hydrolase Inhibition in Liver Diseases: A Review of Current Research and Knowledge Gaps. Biology (Basel) 2020;9:E124. [PMID: 32545637 DOI: 10.3390/biology9060124] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
13 Qi J, Chen LY, Shen XJ, Ju SQ. Analytical Value of Cell-Free DNA Based on Alu in Psychiatric Disorders. Front Psychiatry 2019;10:992. [PMID: 32038328 DOI: 10.3389/fpsyt.2019.00992] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Sun CP, Zhang J, Zhao WY, Yi J, Yan JK, Wang YL, Morisseau C, Liu ZB, Hammock BD, Ma XC. Protostane-type triterpenoids as natural soluble epoxide hydrolase inhibitors: Inhibition potentials and molecular dynamics. Bioorg Chem 2020;96:103637. [PMID: 32032849 DOI: 10.1016/j.bioorg.2020.103637] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
15 Qin X, Wu Z, Dong J, Zeng Y, Xiong W, Liu C, Wang M, Zhu M, Chen W, Zhang Y, Huang Q, Zhu X. Liver Soluble Epoxide Hydrolase Regulates Behavioral and Cellular Effects of Chronic Stress. Cell Reports 2019;29:3223-3234.e6. [DOI: 10.1016/j.celrep.2019.11.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
16 Chhetri DR. Myo-Inositol and Its Derivatives: Their Emerging Role in the Treatment of Human Diseases. Front Pharmacol 2019;10:1172. [PMID: 31680956 DOI: 10.3389/fphar.2019.01172] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 17.3] [Reference Citation Analysis]